COLL
Collegium Pharmaceutical Inc
22.80$
+0.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 12.4% | 9.1% | 59.1% | 65.3% | 42.0% | 45.6% | 54.8% | 42.5% | 40.2% | 40.7% | |
| – | – | 87.6% | 90.9% | 40.9% | 34.7% | 58.0% | 54.4% | 45.2% | 57.5% | 59.8% | 59.3% | |
| – | – | 873.6% | 30.1% | 3.1% | 3.5% | 3.2% | 3.4% | 0.9% | 0.0% | 0.0% | – | |
| – | – | 4,712.6% | 325.7% | 45.2% | 39.2% | 35.0% | 41.5% | 34.6% | 26.8% | 27.3% | 36.5% | |
| – | – | 5,586.2% | 355.8% | 48.3% | 42.7% | 39.9% | 48.0% | 38.0% | 28.1% | 32.9% | 35.4% | |
| – | – | -5,498.7% | -264.9% | -7.4% | -8.0% | 18.1% | 6.4% | 7.2% | 29.5% | 26.9% | 24.0% | |
| – | – | 5.5% | 2.0% | 7.2% | 0.3% | 9.3% | 7.6% | 13.6% | 14.7% | 11.7% | 10.5% | |
| – | – | -5,504.1% | -262.9% | -14.0% | -7.7% | 8.9% | -1.2% | -6.2% | 13.4% | 15.6% | 11.9% | |
| – | – | 5.5% | -4.1% | -39.6% | -4.9% | 0.3% | -27.0% | -0.8% | 4.9% | 4.7% | 3.8% | |
| – | – | -5,504.1% | -262.9% | -14.0% | -7.7% | 8.6% | 25.8% | -5.4% | 8.5% | 11.0% | 8.1% | |
| – | – | -5,460.4% | -260.8% | 32.8% | -2.1% | 38.1% | 31.3% | 37.4% | 54.4% | 54.1% | 51.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.